© 1999 American Heart Association, Inc.
Vascular Biology |
Versican/PG-M Isoforms in Vascular Smooth Muscle Cells
From the Department of Pathology (J.M.L., K.R.B., E.D.K., S.M.S., T.N.W.), University of Washington, Seattle; and the Department of Pharmacology (P.M.), New York University Medical Center, New York. Present address of P.M., Department of Cell Biology, New York University Medical Center, New York, NY 10016.
Correspondence to Joan M. Lemire, Department of Pathology, University of Washington, 1959 NE Pacific Street HSB E-508, Box 357470, Seattle, WA 98195. E-mail joanlemi{at}u.washington.edu
Abstract—The expression of increased amounts of proteoglycans in the extracellular matrix may play a role in vascular stenosis and lipid retention. The large chondroitin sulfate proteoglycan versican is synthesized by vascular smooth muscle cells (SMCs), accumulates during human atherosclerosis and restenosis, and has been shown to bind LDLs. We recently demonstrated that adult rat aortic SMCs express several versican mRNAs. Four versican splice variants, V0, V1, V2, and V3, have recently been described, which differ dramatically in length. These variants differ in the extent of modification by glycosaminoglycan chains, and V3 may lack glycosaminoglycan chains. In this study, we characterized versican RNAs from rat SMCs by cloning, sequencing, and hybridization with domain-specific probes. DNA sequence was obtained for the V3 isoform, and for a truncated V0 isoform. By hybridization of polyadenylated RNA with domain-specific probes, we determined that the V0, V1, and V3 isoforms are present in vascular SMCs. We confirmed the presence of the V3 isoform in polyadenylated RNA and in RT-PCR products by hybridization with an oligonucleotide that spans the splice junction between the hyaluronan-binding domain and the epidermal growth factor-like domain. In addition, a novel splice variant was cloned by PCR amplification from both rat and human SMC RNA. This appears to be an incompletely spliced variant, retaining the final intron. PCR analysis shows that this intron can be retained in both V1 and V3 isoforms. The predicted translation product of this variant would have a different carboxy-terminus than previously described versican isoforms.
Key Words: proteoglycan-M • proteoglycan • splicing • vascular smooth muscle • unspliced
This article has been cited by other articles:
 |
|
 |
|
  W. Sheng, G. Wang, D. P. La Pierre, J. Wen, Z. Deng, C.-K. A. Wong, D. Y. Lee, and B. B. Yang Versican Mediates Mesenchymal-Epithelial Transition Mol. Biol. Cell, April 1, 2006; 17(4): 2009 - 2020. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Huang, M. J. Merrilees, K. Braun, B. Beaumont, J. Lemire, A. W. Clowes, A. Hinek, and T. N. Wight Inhibition of Versican Synthesis by Antisense Alters Smooth Muscle Cell Phenotype and Induces Elastic Fiber Formation In Vitro and in Neointima After Vessel Injury Circ. Res., February 17, 2006; 98(3): 370 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rodriguez-Lee, G. Ostergren-Lunden, B. Wallin, J. Moses, G. Bondjers, and G. Camejo Fatty Acids Cause Alterations of Human Arterial Smooth Muscle Cell Proteoglycans That Increase the Affinity for Low-Density Lipoprotein Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): 130 - 135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Sheng, G. Wang, Y. Wang, J. Liang, J. Wen, P.-S. Zheng, Y. Wu, V. Lee, J. Slingerland, D. Dumont, et al. The Roles of Versican V1 and V2 Isoforms in Cell Proliferation and Apoptosis Mol. Biol. Cell, March 1, 2005; 16(3): 1330 - 1340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-C. Jonsson-Rylander, T. Nilsson, R. Fritsche-Danielson, A. Hammarstrom, M. Behrendt, J.-O. Andersson, K. Lindgren, A.-K. Andersson, P. Wallbrandt, B. Rosengren, et al. Role of ADAMTS-1 in Atherosclerosis: Remodeling of Carotid Artery, Immunohistochemistry, and Proteolysis of Versican Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 180 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. N. Corps, A. H. N. Robinson, T. Movin, M. L. Costa, D. C. Ireland, B. L. Hazleman, and G. P. Riley Versican splice variant messenger RNA expression in normal human Achilles tendon and tendinopathies Rheumatology, August 1, 2004; 43(8): 969 - 972. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. N. Wight and M. J. Merrilees Proteoglycans in Atherosclerosis and Restenosis: Key Roles for Versican Circ. Res., May 14, 2004; 94(9): 1158 - 1167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wu, L. Chen, L. Cao, W. Sheng, and B. B. Yang Overexpression of the C-terminal PG-M/versican domain impairs growth of tumor cells by intervening in the interaction between epidermal growth factor receptor and {beta}1-integrin J. Cell Sci., May 1, 2004; 117(11): 2227 - 2237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wu, W. Sheng, L. Chen, H. Dong, V. Lee, F. Lu, C. S. Wong, W.-Y. Lu, and B. B. Yang Versican V1 Isoform Induces Neuronal Differentiation and Promotes Neurite Outgrowth Mol. Biol. Cell, May 1, 2004; 15(5): 2093 - 2104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hinek, K. R. Braun, K. Liu, Y. Wang, and T. N. Wight Retrovirally Mediated Overexpression of Versican V3 Reverses Impaired Elastogenesis and Heightened Proliferation Exhibited by Fibroblasts from Costello Syndrome and Hurler Disease Patients Am. J. Pathol., January 1, 2004; 164(1): 119 - 131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. MAZZUCATO, M. R. COZZI, P. PRADELLA, D. PERISSINOTTO, A. MALMSTROM, M. MORGELIN, P. SPESSOTTO, A. COLOMBATTI, L. DE MARCO, and R. PERRIS Vascular PG-M/versican variants promote platelet adhesion at low shear rates and cooperate with collagens to induce aggregation FASEB J, December 1, 2002; 16(14): 1903 - 1916. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Cattaruzza, M. Schiappacassi, A. Ljungberg-Rose, P. Spessotto, D. Perissinotto, M. Morgelin, M. T. Mucignat, A. Colombatti, and R. Perris Distribution of PG-M/Versican Variants in Human Tissues and de Novo Expression of Isoform V3 upon Endothelial Cell Activation, Migration, and Neoangiogenesis in Vitro J. Biol. Chem., November 27, 2002; 277(49): 47626 - 47635. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Llorente-Cortes, M. Otero-Vinas, and L. Badimon Differential Role of Heparan Sulfate Proteoglycans on Aggregated LDL Uptake in Human Vascular Smooth Muscle Cells and Mouse Embryonic Fibroblasts Arterioscler. Thromb. Vasc. Biol., November 1, 2002; 22(11): 1905 - 1911. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Ricciardelli, J. H. Brooks, S. Suwiwat, A. J. Sakko, K. Mayne, W. A. Raymond, R. Seshadri, R. G. LeBaron, and D. J. Horsfall Regulation of Stromal Versican Expression by Breast Cancer Cells and Importance to Relapse-free Survival in Patients with Node-negative Primary Breast Cancer Clin. Cancer Res., April 1, 2002; 8(4): 1054 - 1060. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Merrilees, J. M. Lemire, J. W. Fischer, M. G. Kinsella, K. R. Braun, A. W. Clowes, and T. N. Wight Retrovirally Mediated Overexpression of Versican V3 by Arterial Smooth Muscle Cells Induces Tropoelastin Synthesis and Elastic Fiber Formation In Vitro and In Neointima After Vascular Injury Circ. Res., March 8, 2002; 90(4): 481 - 487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Shimizu-Hirota, H. Sasamura, M. Mifune, H. Nakaya, M. Kuroda, M. Hayashi, and T. Saruta Regulation of Vascular Proteoglycan Synthesis by Angiotensin II Type 1 and Type 2 Receptors J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2609 - 2615. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Olsson, A.-C. Egnell, M. R. Lee, G. O. Lunden, M. Lorentzon, M. Salmivirta, G. Bondjers, and G. Camejo Changes in Matrix Proteoglycans Induced by Insulin and Fatty Acids in Hepatic Cells May Contribute to Dyslipidemia of Insulin Resistance Diabetes, September 1, 2001; 50(9): 2126 - 2132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Fischer, M. G. Kinsella, B. Levkau, A. W. Clowes, and T. N. Wight Retroviral Overexpression of Decorin Differentially Affects the Response of Arterial Smooth Muscle Cells to Growth Factors Arterioscler. Thromb. Vasc. Biol., May 1, 2001; 21(5): 777 - 784. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Sandy, J. Westling, R. D. Kenagy, M. L. Iruela-Arispe, C. Verscharen, J. C. Rodriguez-Mazaneque, D. R. Zimmermann, J. M. Lemire, J. W. Fischer, T. N. Wight, et al. Versican V1 Proteolysis in Human Aorta in Vivo Occurs at the Glu441-Ala442 Bond, a Site That Is Cleaved by Recombinant ADAMTS-1 and ADAMTS-4 J. Biol. Chem., April 13, 2001; 276(16): 13372 - 13378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. T. Lee, C. Yamamoto, Y. Feng, S. Potter-Perigo, W. H. Briggs, K. T. Landschulz, T. G. Turi, J. F. Thompson, P. Libby, and T. N. Wight Mechanical Strain Induces Specific Changes in the Synthesis and Organization of Proteoglycans by Vascular Smooth Muscle Cells J. Biol. Chem., April 20, 2001; 276(17): 13847 - 13851. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Merrilees, J. M. Lemire, J. W. Fischer, M. G. Kinsella, K. R. Braun, A. W. Clowes, and T. N. Wight Retrovirally Mediated Overexpression of Versican V3 by Arterial Smooth Muscle Cells Induces Tropoelastin Synthesis and Elastic Fiber Formation In Vitro and In Neointima After Vascular Injury Circ. Res., March 8, 2002; 90(4): 481 - 487. [Abstract] [Full Text] [PDF]
|
|